Insights
Product. Patient. Experience. Insight.
Last 30 days. Every observation is derived from tracked records, states its basis, and is only surfaced above 20 sessions.
Aggregate observations
Data-derived and explainable.
Tinroof shows the highest average reported effectiveness among products with at least 20 tracked sessions.
4.2 / 5 across 481 sessions.
Apple Fritter shows the lowest reported side-effect rate of the compared products.
29.6% of 277 sessions recorded one or more side effects.
Batch AM2502: Higher reported dry eyes than the product average (14.3% vs 9.4%).
112 tracked sessions in the selected window.
Batch AM2503: Higher reported dizziness than the product average (15.3% vs 5.8%).
85 tracked sessions in the selected window.
Batch AM2510: Higher average reported effectiveness than the product average (4.8 vs 4.2).
12 tracked sessions in the selected window.
Patients recording a 2–4 hours experience most often rate the duration as about right.
83.2% of 416 sessions in that band.
74.7% of tracked patients recorded another session within 30 days of their first recorded experience.
292 of 391 patients. Measures tracking behaviour, not medicine adherence.
Reported outcome by amount
Descriptive research view. Not dosing guidance.
Anxiety / paranoia reporting
Rate by medicine
Based on 1,097 sessions
Observations describe reported experience in aggregate. They are not treatment recommendations, product recommendations, dosing guidance, or causal conclusions.